HIGHLIGHTS
- who: Willem A. Hanekom from the Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Department of Molecular have published the research: Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB, in the Journal: (JOURNAL)
- what: Recent clinical trials showing partial vaccine efficacy against established Mtb infection and progression to TB disease provide the first opportunity to discover immune correlates of protection in humans.
- future: Future directions for targeting Th17 responses should involve careful analysis in ongoing studies to identify if Th17 cells or IL-17 production in innate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.